COVID-19検査市場：キットタイプ、検査タイプ、検体タイプ、用途別-2025-2030年の世界予測

COVID-19検査市場は、2023年に388億4,000万米ドルと評価され、2024年には426億2,000万米ドルに達すると予測され、CAGR 10.20%で成長し、2030年には766億9,000万米ドルになると予測されています。

COVID-19検査市場の範囲と定義は、個人におけるSARS-CoV-2ウイルスの検出に使用される診断ツールの生産と流通を包含します。この市場には主にPCR検査、抗原検査、抗体検査が含まれ、ウイルスの隔離、治療、トランスミッションの予防のために感染を迅速に診断することを目的としています。COVID-19検査の必要性は、パンデミックの際、公衆衛生管理における重要なツールとして注目され、ヘルスケア分野だけでなく、職場や地域社会が安全に機能することを保証することで経済活動にも影響を及ぼしました。検査の用途は、臨床の場だけにとどまらず、旅行、娯楽、教育、職場などの分野にも浸透しており、最終用途の広さを示しています。

市場開拓の洞察によると、公衆衛生への関心の高まりや、より効率的で迅速な診断検査の開発に対する政府の支援といった要因によって、堅調な成長が見込まれています。特に、在宅検査キット、効率的な結果管理のためのデジタルヘルス統合、ウェアラブル・バイオセンサーを使用した新しいタイプの検査などの革新的な検査技術には、潜在的なビジネスチャンスをもたらす環境が整っています。しかし、検査精度のばらつき、サプライチェーンの制約、市場参入における規制上のハードルなどの課題は依然として残っており、市場拡大に影響を及ぼす可能性があります。さらに、検査へのアクセスにおける格差は、検査市場全体の浸透に影響を及ぼす重大な問題として残っています。

技術革新のチャンスは、より費用対効果が高く、迅速でアクセスしやすい検査ソリューションを開発することにあり、流通しやすいPOCシステムに重点が置かれています。また、データ解釈を強化する人工知能や機械学習、遠隔モニタリングや検査のための遠隔医療システムにも成長の可能性があります。市場力学は順応的であり、規制の変更、技術の進歩、新たな変種や公衆衛生政策による需要の変動に影響されるダイナミックで競合的な性質を持っています。持続的な成長のためには、企業はサプライチェーンの回復力の向上、検査ロジスティクスのためのデジタルインフラの拡大、新たな公衆衛生ニーズに対応するための多様な検査ソリューションのための協力関係の構築に注力すべきです。

市場力学：急速に進化するCOVID-19検査市場の主要市場インサイトを公開

COVID-19検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界のCOVID-19感染患者数の増加
  • 大量検査の実施に向けた政府のイニシアティブの高まり
  • 改良型COVID-19検査キットの製造に向けた活発な取り組み
• 市場抑制要因
  • 診断キットの不足に関する懸念
• 市場機会
  • 新規参入企業の在宅検査への注力と高度なソフトウェアの統合
  • COVID-19検査デバイスの開発とイノベーション
• 市場の課題
  • 誤った検査結果に関する問題

ポーターの5つの力：COVID-19検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、COVID-19検査市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：COVID-19検査市場における外部からの影響の把握

外部マクロ環境要因は、COVID-19検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析COVID-19検査市場における競合情勢の把握

COVID-19検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスCOVID-19検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、COVID-19検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨COVID-19検査市場における成功への道筋を描く

COVID-19検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中でCOVID-19感染者数が増加
    • 大規模検査の実施に向けた政府の取り組みの高まり
    • 改良されたCOVID-19検査キットの製造に多額の投資
  • 抑制要因
    • 診断キットの不足に伴う懸念
  • 機会
    • 新規参入企業は在宅検査と高度なソフトウェアの統合に注力
    • COVID-19検査デバイスの開発と革新
  • 課題
    • 誤った検査結果に関する問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 COVID-19検査市場キットタイプ別

• 迅速検査キット
• リアルタイム逆転写ポリメラーゼ連鎖反応（RT-PCR）

第7章 COVID-19検査市場テストタイプ別

• マルチプレックスNAAT
• NAATポイントオブケア
• シングルプレックス核酸増幅検査

第8章 COVID-19検査市場標本の種類別

• 血
• 鼻腔スワブ
• 鼻咽頭スワブ
• 口腔咽頭スワブ
• 尿

第9章 COVID-19検査市場：用途別

• クリニック
• 診断センター
• 病院

第10章 南北アメリカのCOVID-19検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のCOVID-19検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのCOVID-19検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AccuBioTech Co. Ltd.
• ADT Biotech
• AIVD Biotech Inc.
• Altona Diagnostics GmbH
• AMEDA Labordiagnostik GmbH
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Cepheid Inc.
• Coris BioConcept SPRL
• Danaher Corporation
• F. Hoffmann-La Roche AG
• GenBody America, LLC
• Genuine Biosystem Pvt. Ltd.
• Hologic Inc.
• LAB-CARE DIAGNOSTICS（INDIA）PVT. LTD.
• Laboratory Corporation of America Holdings
• Luminex Corporation
• PerkinElmer Inc.
• Quest Diagnostics Inc.
• Quidel Corporation
• SD Biosensor, Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. COVID-19 TESTING MARKET RESEARCH PROCESS
• FIGURE 2. COVID-19 TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COVID-19 TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. COVID-19 TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. COVID-19 TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COVID-19 TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COVID-19 TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COVID-19 TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COVID-19 TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COVID-19 TESTING MARKET SIZE, BY RAPID TEST KIT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COVID-19 TESTING MARKET SIZE, BY REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR), BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COVID-19 TESTING MARKET SIZE, BY MULTIPLEX NAATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COVID-19 TESTING MARKET SIZE, BY NAAT POINT OF CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COVID-19 TESTING MARKET SIZE, BY SINGLEPLEX NUCLEIC ACID AMPLIFICATION TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COVID-19 TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASAL SWAB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COVID-19 TESTING MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COVID-19 TESTING MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL COVID-19 TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL COVID-19 TESTING MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL COVID-19 TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL COVID-19 TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CANADA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 40. CANADA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES COVID-19 TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. CHINA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CHINA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA COVID-19 TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. ITALY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 135. ITALY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. POLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 151. POLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. QATAR COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 155. QATAR COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY KIT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY SPECIMEN TYPE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM COVID-19 TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 192. COVID-19 TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 193. COVID-19 TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The COVID-19 Testing Market was valued at USD 38.84 billion in 2023, expected to reach USD 42.62 billion in 2024, and is projected to grow at a CAGR of 10.20%, to USD 76.69 billion by 2030.

The scope and definition of the COVID-19 testing market encompass the production and distribution of diagnostic tools used to detect the SARS-CoV-2 virus in individuals. This market primarily includes PCR tests, antigen tests, and antibody tests, structured to promptly diagnose infection for timely isolation, treatment, and prevention of virus transmission. The necessity of COVID-19 testing was highlighted during the pandemic as a crucial tool in managing public health, supporting not just the healthcare sector but also influencing economic activities by ensuring workplaces and communities can function safely. Testing applications extend beyond clinical settings, permeating sectors such as travel, entertainment, education, and workplaces, marking its widespread end-use scope.

Market insights indicate robust growth driven by factors such as a heightened public health focus and government support for developing more efficient and rapid diagnostic tests. There's a conducive environment for potential opportunities, particularly in innovative testing technologies like at-home testing kits, digital health integration for efficient results management, and novel test types using wearable biosensors. However, challenges endure, including variability in test accuracy, supply chain constraints, and regulatory hurdles in market entry, which may impact market expansion. Furthermore, disparities in testing access remain a critical issue affecting overall testing market penetration.

Innovation opportunities lie in developing more cost-effective, rapid, and accessible testing solutions, with emphasis on easy-to-distribute Point-of-Care systems. There's also potential growth in artificial intelligence and machine learning to enhance data interpretation and in telehealth systems for remote monitoring and testing. The COVID-19 testing market is adaptive, with a dynamic and competitive nature influenced by regulatory changes, technological advancements, and fluctuating demand driven by new variants and public health policies. For sustained growth, businesses should focus on improving supply chain resilience, expanding digital infrastructure for testing logistics, and forging collaborations for diversified testing solutions to cater to emergent public health needs.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving COVID-19 Testing Market

The COVID-19 Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing number of COVID-19-infected patients globally
  • Rising government initiatives toward the implementation of mass testing
  • Significant invetsments to manufacture improved COVID-19 testing kits
• Market Restraints
  • Concerns associated with scarcity of diagnostic kits
• Market Opportunities
  • Focus of new entrants toward at-home testing and integration of advanced software
  • Development and innovations in COVID-19 testing devices
• Market Challenges
  • Issues pertaining to false test results

Porter's Five Forces: A Strategic Tool for Navigating the COVID-19 Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the COVID-19 Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the COVID-19 Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the COVID-19 Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the COVID-19 Testing Market

A detailed market share analysis in the COVID-19 Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the COVID-19 Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the COVID-19 Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the COVID-19 Testing Market

A strategic analysis of the COVID-19 Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the COVID-19 Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co. Ltd., ADT Biotech, AIVD Biotech Inc., Altona Diagnostics GmbH, AMEDA Labordiagnostik GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Cepheid Inc., Coris BioConcept SPRL, Danaher Corporation, F. Hoffmann-La Roche AG, GenBody America, LLC, Genuine Biosystem Pvt. Ltd., Hologic Inc., LAB-CARE DIAGNOSTICS (INDIA) PVT. LTD., Laboratory Corporation of America Holdings, Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Inc., Quidel Corporation, SD Biosensor, Inc., Siemens Healthineers AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the COVID-19 Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Kit Type, market is studied across Rapid Test Kit and Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR).
• Based on Test Type, market is studied across Multiplex NAATs, NAAT Point of Care, and Singleplex Nucleic Acid Amplification Tests.
• Based on Specimen Type, market is studied across Blood, Nasal Swab, Nasopharyngeal Swab, Oropharyngeal Swab, and Urine.
• Based on Application, market is studied across Clinics, Diagnostic Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing number of COVID-19-infected patients globally
    • 5.1.1.2. Rising government initiatives toward the implementation of mass testing
    • 5.1.1.3. Significant invetsments to manufacture improved COVID-19 testing kits
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns associated with scarcity of diagnostic kits
  • 5.1.3. Opportunities
    • 5.1.3.1. Focus of new entrants toward at-home testing and integration of advanced software
    • 5.1.3.2. Development and innovations in COVID-19 testing devices
  • 5.1.4. Challenges
    • 5.1.4.1. Issues pertaining to false test results
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. COVID-19 Testing Market, by Kit Type

• 6.1. Introduction
• 6.2. Rapid Test Kit
• 6.3. Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR)

7. COVID-19 Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Multiplex NAATs
• 7.3. NAAT Point of Care
• 7.4. Singleplex Nucleic Acid Amplification Tests

8. COVID-19 Testing Market, by Specimen Type

• 8.1. Introduction
• 8.2. Blood
• 8.3. Nasal Swab
• 8.4. Nasopharyngeal Swab
• 8.5. Oropharyngeal Swab
• 8.6. Urine

9. COVID-19 Testing Market, by Application

• 9.1. Introduction
• 9.2. Clinics
• 9.3. Diagnostic Centers
• 9.4. Hospitals

10. Americas COVID-19 Testing Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific COVID-19 Testing Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa COVID-19 Testing Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AccuBioTech Co. Ltd.
• 3. ADT Biotech
• 4. AIVD Biotech Inc.
• 5. Altona Diagnostics GmbH
• 6. AMEDA Labordiagnostik GmbH
• 7. Becton, Dickinson and Company
• 8. Bio-Rad Laboratories, Inc.
• 9. bioMerieux SA
• 10. Cepheid Inc.
• 11. Coris BioConcept SPRL
• 12. Danaher Corporation
• 13. F. Hoffmann-La Roche AG
• 14. GenBody America, LLC
• 15. Genuine Biosystem Pvt. Ltd.
• 16. Hologic Inc.
• 17. LAB-CARE DIAGNOSTICS (INDIA) PVT. LTD.
• 18. Laboratory Corporation of America Holdings
• 19. Luminex Corporation
• 20. PerkinElmer Inc.
• 21. Quest Diagnostics Inc.
• 22. Quidel Corporation
• 23. SD Biosensor, Inc.
• 24. Siemens Healthineers AG
• 25. Thermo Fisher Scientific Inc.